Cointime

MBF Therapeutics

company

About

MBF Therapeutics advances the standard of cancer care for companion animals by developing innovative products.

  • 1 - 10

Highlights

Total Funding Amount
$506K
Funding Rounds
2
Investors
2

Details

Last Funding Type
Grant
Last Funding Money Raised
$256K
Industries
Biotechnology,Life Science,Therapeutics,Veterinary
Founded date
Jan 1, 2008
Number Of Employee
1 - 10
Operating Status
Active

MBF Therapeutics is a clinical-stage animal health company focusing on the development of gene-based, immunotherapeutic vaccines for use in veterinary medicine.

Using proprietary vaccine platform and delivery system technology, MBF Therapeutics’ checkpoint inhibitor therapies have the potential of transforming the treatment of cancer and prevention of infectious diseases in companion animals and livestock.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$506K
MBF Therapeutics has raised a total of $506K in funding over 2 rounds. Their latest funding was raised on Dec 21, 2021 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 21, 2021 Grant $256K 1 National Science Foundation — Detail
May 16, 2018 Seed $250K 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
1
2
MBF Therapeutics is funded by 2 investors. National Science Foundation and StartUp PHL are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant
StartUp PHL — Seed
Cointime
Chủ Đề
Công Ty